Payden & Rygel’s Invesco IVZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-41,700
Closed -$1.11M 120
2018
Q2
$1.11M Hold
41,700
0.09% 72
2018
Q1
$1.33M Buy
+41,700
New +$1.44M 0.11% 73
2017
Q3
Sell
-300,000
Closed -$10.6M 121
2017
Q2
$10.6M Hold
300,000
0.92% 48
2017
Q1
$9.19M Hold
300,000
0.84% 55
2016
Q4
$9.1M Hold
300,000
0.84% 55
2016
Q3
$9.38M Sell
300,000
-62,200
-17% -$1.83M 0.94% 49
2016
Q2
$9.25M Buy
362,200
+84,900
+31% +$2.52M 1.05% 46
2016
Q1
$8.53M Buy
+277,300
New +$8M 1.04% 51

Other funds holding IVZ

Payden & Rygel's IVZ Position: Q3 2018 in Review

Payden & Rygel sold out of Invesco (IVZ) in Q3 2018, closing a stake of 41,700 shares — an estimated $1.11M sold.

Payden & Rygel first reported a position in IVZ in Q1 2016 and held it in 8 quarters. The position peaked at $10.6M in Q2 2017. 565 funds tracked by Wall St. Rank hold IVZ as of Q3 2018.

  • Payden & Rygel reported no remaining Invesco position as of Q3 2018 after selling out during the quarter.
  • Payden & Rygel sold 41,700 Invesco shares in Q3 2018, an estimated $1.11M.
  • Payden & Rygel first reported a position in Invesco in Q1 2016 and held it in 8 quarters.
  • Payden & Rygel's Invesco position peaked at $10.6M in Q2 2017.
  • 565 funds tracked by Wall St. Rank held Invesco as of Q3 2018.

Based on Payden & Rygel's 13F filing for Q3 2018, filed 7 Nov 2018.